Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 1.69
(0.0%)
CNY 1.69
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.94 Billion CNY | -66.37% |
| 2022 | 5.58 Billion CNY | 35.05% |
| 2021 | 4.13 Billion CNY | 318.43% |
| 2020 | 988.8 Million CNY | -27.29% |
| 2019 | 1.35 Billion CNY | 2.39% |
| 2018 | 1.32 Billion CNY | 10.42% |
| 2017 | 1.2 Billion CNY | 45.55% |
| 2016 | 826.36 Million CNY | 31.64% |
| 2015 | 627.75 Million CNY | 36.97% |
| 2014 | 458.31 Million CNY | 49.19% |
| 2013 | 307.19 Million CNY | -52.92% |
| 2012 | 652.55 Million CNY | -19.17% |
| 2011 | 807.36 Million CNY | 75.73% |
| 2010 | 459.44 Million CNY | 130.59% |
| 2009 | 199.24 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 190.46 Million CNY | -58.15% |
| 2024 Q3 | 174.24 Million CNY | -38.65% |
| 2024 Q2 | 284.03 Million CNY | 49.12% |
| 2023 Q3 | 582.21 Million CNY | 70.88% |
| 2023 Q4 | 455.15 Million CNY | -21.82% |
| 2023 FY | 1.87 Billion CNY | -66.37% |
| 2023 Q1 | 624.97 Million CNY | -21.35% |
| 2023 Q2 | 340.7 Million CNY | -45.48% |
| 2022 Q2 | 2.14 Billion CNY | 46.16% |
| 2022 FY | 5.58 Billion CNY | 35.05% |
| 2022 Q4 | 794.6 Million CNY | -32.44% |
| 2022 Q1 | 1.46 Billion CNY | 14.89% |
| 2022 Q3 | 1.17 Billion CNY | -45.24% |
| 2021 Q3 | 1.5 Billion CNY | 63.39% |
| 2021 Q4 | 1.27 Billion CNY | -14.9% |
| 2021 FY | 4.13 Billion CNY | 318.43% |
| 2021 Q1 | 435.89 Million CNY | 90.53% |
| 2021 Q2 | 919.77 Million CNY | 111.01% |
| 2020 Q2 | 250.76 Million CNY | 48.98% |
| 2020 Q3 | 340.95 Million CNY | 35.97% |
| 2020 Q4 | 228.77 Million CNY | -32.9% |
| 2020 FY | 988.8 Million CNY | -27.29% |
| 2020 Q1 | 168.31 Million CNY | -39.42% |
| 2019 FY | 1.35 Billion CNY | 2.39% |
| 2019 Q4 | 277.84 Million CNY | -31.46% |
| 2019 Q1 | 286.49 Million CNY | -6.66% |
| 2019 Q2 | 390.18 Million CNY | 36.2% |
| 2019 Q3 | 405.39 Million CNY | 3.9% |
| 2018 Q3 | 391.37 Million CNY | -8.12% |
| 2018 FY | 1.32 Billion CNY | 10.42% |
| 2018 Q4 | 306.94 Million CNY | -21.57% |
| 2018 Q2 | 425.97 Million CNY | 108.91% |
| 2018 Q1 | 203.89 Million CNY | -51.21% |
| 2017 Q1 | 300.79 Million CNY | 14.45% |
| 2017 Q2 | 225.47 Million CNY | -25.04% |
| 2017 Q3 | 258.58 Million CNY | 14.68% |
| 2017 Q4 | 417.94 Million CNY | 61.63% |
| 2017 FY | 1.2 Billion CNY | 45.55% |
| 2016 Q2 | 191.13 Million CNY | 23.48% |
| 2016 FY | 826.36 Million CNY | 31.64% |
| 2016 Q4 | 262.82 Million CNY | 20.78% |
| 2016 Q1 | 154.79 Million CNY | -23.8% |
| 2016 Q3 | 217.61 Million CNY | 13.85% |
| 2015 Q2 | 187.31 Million CNY | 84.34% |
| 2015 Q4 | 203.15 Million CNY | 49.74% |
| 2015 Q3 | 135.67 Million CNY | -27.57% |
| 2015 Q1 | 101.61 Million CNY | -42.1% |
| 2015 FY | 627.75 Million CNY | 36.97% |
| 2014 FY | 458.31 Million CNY | 49.19% |
| 2014 Q3 | 103.24 Million CNY | 19.74% |
| 2014 Q1 | 93.34 Million CNY | -18.87% |
| 2014 Q4 | 175.49 Million CNY | 69.97% |
| 2014 Q2 | 86.22 Million CNY | -7.63% |
| 2013 FY | 307.19 Million CNY | -52.92% |
| 2013 Q2 | 54.4 Million CNY | -40.54% |
| 2013 Q3 | 46.22 Million CNY | -15.05% |
| 2013 Q1 | 91.49 Million CNY | 6.92% |
| 2013 Q4 | 115.06 Million CNY | 148.95% |
| 2012 Q2 | 227.27 Million CNY | 1.61% |
| 2012 Q4 | 85.57 Million CNY | -26.24% |
| 2012 Q1 | 223.68 Million CNY | -13.25% |
| 2012 Q3 | 116.02 Million CNY | -48.95% |
| 2012 FY | 652.55 Million CNY | -19.17% |
| 2011 FY | 807.36 Million CNY | 75.73% |
| 2011 Q3 | 259.24 Million CNY | 0.0% |
| 2011 Q4 | 257.84 Million CNY | -0.54% |
| 2010 FY | 459.44 Million CNY | 130.59% |
| 2009 FY | 199.24 Million CNY | 0.0% |